Description
Retatrutide (LY3437943) is a tri-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously—a profile that distinguishes it from dual-agonist comparators in metabolic research models. HALO Research Supplies provides Retatrutide as lyophilized powder at ≥98% purity (HPLC), with each batch accompanied by an independent certificate of analysis confirming identity and purity.
In preclinical research settings, Retatrutide is studied for its effects on energy metabolism, adipose tissue signalling, and insulin secretion pathways. Available in a broad dose range (5 mg–100 mg) to support dose-response study design.
| Format | Lyophilized powder |
|---|---|
| Purity | ≥98% HPLC |
| Storage | −20°C desiccated, light-protected |
| Reconstitution | Bacteriostatic water; use within 28 days at 4°C |
Research Use Only. Not for human or veterinary use. For qualified laboratory research only. See RUO statement.




